The ECS Affects Most Disease That Has an Inflammation Related Component

 

 

CLICK ON UNDERLINED TEXT FOR MORE INFORAMTION

 

The ECS is a homeostatic regulator of inflammation and has been shown to play a key role in affecting various diseases associated with inflammation.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source Photo

 

 

 

 

 

Various diseases that the ECS has been shown to have an impact on in clinical trials range from epilepsy to autism. FDA trials are currently underway to bring phytocannabinoids to market that affect said diseases as well as:

 

• Achilles tendinosis

• ADHD

• Alzheimer's

• Amyotrophic lateral sclerosis (ALS)

• Anxiety

• Atherosclerosis

• Chronic Pain

• Crohn's/IBD

• Depression

• Diabetes, Type 2

• Dravet Syndrome

• Dystonia

• Epilepsy

• Fibromyalgia

• Fibrosis

• Glaucoma

• Glioma brain tumors

• Hepatitis C

• HIV

• Huntington's Disease

• Hypertension

• Incontinence

• Lennox-Gastaut Syndrome

• MS Spasticity

• Myocardial Infarction

• Migraines

• Miscarriage

• MRSA

• Muscular Dystrophy

• Neo-natal Hypoxic Ischemic Encephalopathy

• Neuropathic Pain

• Neuropsychiatric Disorders

• Obesity

• Obesity/Metabolic Syndrome

• Osteoporosis

• Parkinson's Disease

• Pruritus

• PTSD

• Rheumatoid Arthritis

• Schizophrenia

• Sleep Apnea

• Tobacco Addiction

• Tourette's Syndrome

• Tuberous Sclerosis